Settable bone void filler
The invention provides composite materials that form a biocompatible and bioresorbable settable ceramic-forming composition, and that possesses high strength when set and other desirable mechanical properties. The composite materials may include additive materials that provide beneficial advantages in the handling and physical properties of the material. When a hydrated precursor, the composite material is capable of being injected through cannulas for placement in treatment sites. The composite material provided desirable handling properties and sets in a clinically relevant time period.
1. A composition for forming a bone cement comprising:
a. a reactive apatite forming composition in the form of a plurality of particles that will together react to form an apatitic calcium phosphate due to cementitious hardening in the presence of a hydrating fluid, wherein the reactive apatite forming composition comprises a mixture of discrete particles and wherein each particle of the mixture consists of monocalcium phosphate monohydrate, monocalcium phosphate anhydrous, dicalcium phosphate anhydrous, dicalcium phosphate dihydrate, octacalcium phosphate, alpha-tricalcium phosphate, beta-tricalcium phosphate, amorphous calcium phosphate, calcium deficient hydroxyapatite, hydroxyapatite, tetracalcium phosphate, CaSO 4 , CaSO 4 ·0.5H 2 O, CaSO 4 ·2H 2 O, CaO, Ca(OH) 2 , CaCO 3 , or a mixture of two or more of the foregoing;
b. particles of a water soluble polymer; and
c. particles of a swelling additive comprising non-enzymatically processed, acid soluble collagen;
wherein, if contacted with a suitable amount of a hydrating fluid, the composition forms a hydrated precursor within which the swelling additive is suspended as a particle and thereafter hardens to an apatitic calcium phosphate via cementitious hardening of the reactive apatite forming composition.
2. The composition of claim 1 , wherein the reactive apatite forming composition comprises powder particles having a size of from 1 pm to 50 μm.
3. The composition of claim 1 , wherein the reactive apatite forming composition comprises a mixture of discrete particles, wherein each particle of the mixture consists of monocalcium phosphate monohydrate, monocalcium phosphate anhydrous, dicalcium phosphate anhydrous, dicalcium phosphate dihydrate, octacalcium phosphate, alpha-tricalcium phosphate, beta-tricalcium phosphate, amorphous calcium phosphate, calcium deficient hydroxyapatite, hydroxyapatite, tetracalcium phosphate, CaSO 4 , CaSO 4 ·0.5H 2 O, CaSO 4 ·2H 2 O, CaO, Ca(OH) 2 , or CaCO 3 .
4. The composition of claim 1 , wherein the reactive apatite forming composition comprises discrete particles of a calcium phosphate.
5. The composition of claim 1 , wherein the reactive apatite forming composition consists of:
i. particles consisting of tetracalcium phosphate,
ii. particles consisting of hydroxyapatite,
iii. particles consisting of monocalcium phosphate monohydrate,
iv. particles consisting of alpha-tricalcium phosphate, and
v. particles consisting of sodium phosphate dibasic dihydrate.
6. The composition of claim 1 , wherein said water soluble polymer comprises polyalkylene oxide, polyvinylpyrrolidone, polyvinyl alcohol, hyaluronic acid, or a combination thereof.
7. The composition of claim 1 , wherein said water soluble polymer consists of polyalkylene oxide, polyvinylpyrrolidone, polyvinyl alcohol, hyaluronic acid, or a combination thereof.
8. The composition of claim 1 , wherein said water soluble polymer comprises polyethylene glycol.
9. The composition of claim 1 , further comprising particles of poly(lactic-co-glycolic acid).
10. The composition of claim 1 , further comprising particles of bioactive glass.
11. The composition of claim 1 , further comprising demineralized bone powder.
12. The composition according to claim 1 , wherein the composition comprises particles comprising both the water soluble polymer and the non-enzymatically processed, acid soluble collagen together.
13. The composition of claim 1 , further comprising a buffering agent in the form of a plurality of particles.
14. A composition comprising:
a. discrete particles consisting of tetracalcium phosphate,
b. discrete particles consisting of hydroxyapatite,
c. discrete particles consisting of monocalcium phosphate monohydrate,
d. discrete particles consisting of alpha-tricalcium phosphate,
e. discrete particles consisting of sodium phosphate dibasic dihydrate,
f. discrete particles comprising polyethylene glycol, and
g. discrete particles comprising acid soluble collagen.
15. The composition of claim 14 , further comprising particles of poly(lactic-co-glycolic acid).
16. The composition of claim 14 , further comprising particles of bioactive glass.
17. The composition of claim 14 , further comprising demineralized bone powder.
18. A composition for forming a bone cement comprising:
a. a reactive apatite forming composition in the form of a plurality of discrete particles that will together react to form an apatitic calcium phosphate due to cementitious hardening in the presence of a hydrating fluid, wherein the reactive apatite forming composition comprises a mixture of discrete particles and wherein each particle of the mixture consists of monocalcium phosphate monohydrate, monocalcium phosphate anhydrous, dicalcium phosphate anhydrous, dicalcium phosphate dihydrate, octacalcium phosphate, alpha-tricalcium phosphate, beta-tricalcium phosphate, amorphous calcium phosphate, calcium deficient hydroxyapatite, hydroxyapatite, tetracalcium phosphate, CaSO 4 , CaSO 4 ·0.5H 2 O, CaSO 4 ·2H 2 O, CaO, Ca(OH) 2 , CaCO 3 , or a mixture of two or more of the foregoing; and
b. particles comprising polyethylene glycol and non-enzymatically processed, acid soluble collagen;
wherein, if contacted with a suitable amount of a hydrating fluid, the composition forms a hydrated precursor within which the swelling additive is suspended as a particle and thereafter hardens to an apatitic calcium phosphate via cementitious hardening of the reactive apatite forming composition.
19. A method of treating a tissue defect comprising the steps of:
a. combining a hydrating fluid and a composition according to claim 1 and mixing, thereby forming a hydrated composition,
b. placing the hydrated composition at the site of a tissue defect in a patient; and
c. allowing the hydrated composition to harden to an apatitic calcium phosphate.
20. A method of treating a tissue defect comprising the steps of:
a. combining a hydrating fluid and a composition according to claim 14 and mixing, thereby forming a hydrated composition,
b. placing the hydrated composition at the site of a tissue defect in a patient; and
c. allowing the hydrated composition to harden to an apatitic calcium phosphate.
21. A method of treating a tissue defect comprising the steps of:
a. combining a hydrating fluid and a composition according to claim 18 and mixing, thereby forming a hydrated composition,
b. placing the hydrated composition at the site of a tissue defect in a patient; and
c. allowing the hydrated composition to harden to an apatitic calcium phosphate.